Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paroma Chakravarty

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Molecular Pharmaceutics|September 15, 2018
Understanding Phase Behavior of Nearly Energetically Equivalent Polymorphs To Achieve Controlled Crystallization for a Nav1.7 Pain Inhibitor CompoundParoma Chakravarty, Antonio G DiPasquale, Andreas Stumpf, et al.
Journal of Pharmaceutical Sciences|July 23, 2009
Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part IParoma Chakravarty, Robert T Berendt, Eric J Munson, et al.
Journal of Pharmaceutical Sciences|October 14, 2009
Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part IIParoma Chakravarty, Robert T Berendt, Eric J Munson, et al.
Molecular Pharmaceutics|July 10, 2025
Combination of Hydroxypropyl-Beta-Cyclodextrin and Trehalose for Improved Stability of Spray-Dried Monoclonal AntibodiesYu Tong Tam, Aadithya Kannan, Paroma Chakravarty, et al.
Journal of Pharmaceutical Sciences|November 4, 2022
Professor Raj Suryanarayanan: Scientist, Educator, Mentor, Family Man and Giant in Pharmaceutical ResearchParoma Chakravarty, Alekha Dash, Evgenyi Shalaev, et al.
Journal of Pharmaceutical Sciences|January 15, 2019
Cyclodextrin Reduces Intravenous Toxicity of a Model CompoundPriscilla Mantik, Minli Xie, Harvey Wong, et al.
Journal of Medicinal Chemistry|May 12, 2016
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic WindowJoachim Rudolph, Lesley J Murray, Chudi O Ndubaku, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Pharmaceutics|September 15, 2018
Understanding Phase Behavior of Nearly Energetically Equivalent Polymorphs To Achieve Controlled Crystallization for a Nav1.7 Pain Inhibitor CompoundParoma Chakravarty, Antonio G DiPasquale, Andreas Stumpf, et al.
Journal of Pharmaceutical Sciences|July 23, 2009
Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part IParoma Chakravarty, Robert T Berendt, Eric J Munson, et al.
Journal of Pharmaceutical Sciences|October 14, 2009
Insights into the dehydration behavior of thiamine hydrochloride (vitamin B1) hydrates: part IIParoma Chakravarty, Robert T Berendt, Eric J Munson, et al.
Molecular Pharmaceutics|July 10, 2025
Combination of Hydroxypropyl-Beta-Cyclodextrin and Trehalose for Improved Stability of Spray-Dried Monoclonal AntibodiesYu Tong Tam, Aadithya Kannan, Paroma Chakravarty, et al.
Journal of Pharmaceutical Sciences|November 4, 2022
Professor Raj Suryanarayanan: Scientist, Educator, Mentor, Family Man and Giant in Pharmaceutical ResearchParoma Chakravarty, Alekha Dash, Evgenyi Shalaev, et al.
Journal of Pharmaceutical Sciences|January 15, 2019
Cyclodextrin Reduces Intravenous Toxicity of a Model CompoundPriscilla Mantik, Minli Xie, Harvey Wong, et al.
Journal of Medicinal Chemistry|May 12, 2016
Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic WindowJoachim Rudolph, Lesley J Murray, Chudi O Ndubaku, et al.
Journal of Medicinal Chemistry|May 11, 2013
Identification of C-2 hydroxyethyl imidazopyrrolopyridines as potent JAK1 inhibitors with favorable physicochemical properties and high selectivity over JAK2Mark Zak, Christopher A Hurley, Stuart I Ward, et al.
Pageof 3